T-cell immunoglobulin domain and mucin domain-3 (TIM-3) is another biomarker of interest, as its ligand (Galectin-9), along with PD-L1, are both upregulated during tumor progression [104]. This evidence concerns the gene HAVCR2 and neoplasm.